Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become a for-profit corporation, and he regularly trolls the company on X—the platform he bought for $44 billion back in 2022. All of which is why the past week has been hilarious.

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance, and event planning.

Sam Altman has told OpenAI fans to lower their expectations after rumors the company had achieved AGI went viral on X.

Musk has raised questions on project Stargate, the $500bn AI project. This lead to a verbal spat between him and Sam Altman.

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO slammed the new artificial intelligence (AI) infrastructure project,

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC has learned.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as saying that Sam Altman is participating in the investment. He previously provided the initial $180 million funding round that helped launch Retro.

OpenAI CEO Sam Altman suggested Elon Musk cares more about his businesses than he does the country, shortly after he referred to Musk as "the most inspiring entrepreneur of our time."

OpenAI CEO Sam Altman surprised the tech world on Thursday with the launch of Operator, his company’s first AI agent that can act autonomously on the web. However, OpenAI is not the only venture of Altman’s that’s focused on AI agents.